TP53 and lung adenocarcinoma: In addition, TP53 mutations can be detected in 50–60% of human cancers, and some mutated proteins play a cancer-promoting role in tumors such as colon cancer, head and neck squamous cell carcinoma, and lung adenocarcinoma [32,33,34].